Australia's Sigma withdraws from $10 billion Boots bid

Sigma Healthcare withdrew from the sale process for UK retailer Boots after concluding the up to $10 billion acquisition would not meet its strategic or capital-investment objectives. The Australian pharmacy distributor said it completed a preliminary review and "elected to cease discussions immediately," according to Bloomberg, sending Sigma shares higher as investors welcomed the capital discipline. Boots, owned by Sycamore Partners, remains in talks with other bidders including Canada's Weston family, though Sigma's exit narrows the field of strategic buyers and could affect competitive tension in the auction. The withdrawal underscores the challenges facing large bricks-and-mortar pharmacy chains in mature markets as strategic buyers balk at the risk-return profile.